Cargando…

Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49

BACKGROUND: Canadian and US Task Forces recommend against routine mammography screening for women age 40–49 at average breast cancer risk as harms outweigh benefits. Both suggest individualized decisions based on the relative value women place on potential screening benefits and harms. Population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadler, Michelle B., Corrado, Ann Marie, Wilson, Brooke E., Desnoyers, Alexandra, Amir, Eitan, Ivers, Noah, Desveaux, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942408/
https://www.ncbi.nlm.nih.gov/pubmed/36803461
http://dx.doi.org/10.1186/s12905-023-02190-w
_version_ 1784891493745426432
author Nadler, Michelle B.
Corrado, Ann Marie
Wilson, Brooke E.
Desnoyers, Alexandra
Amir, Eitan
Ivers, Noah
Desveaux, Laura
author_facet Nadler, Michelle B.
Corrado, Ann Marie
Wilson, Brooke E.
Desnoyers, Alexandra
Amir, Eitan
Ivers, Noah
Desveaux, Laura
author_sort Nadler, Michelle B.
collection PubMed
description BACKGROUND: Canadian and US Task Forces recommend against routine mammography screening for women age 40–49 at average breast cancer risk as harms outweigh benefits. Both suggest individualized decisions based on the relative value women place on potential screening benefits and harms. Population-based data reveal variation in primary care professionals (PCPs) mammography rates in this age group after adjusting for sociodemographic factors, highlighting the need to explore PCP screening perspectives and how this informs clinical behaviours. Results from this study will inform interventions that can improve guideline concordant breast screening for this age group. METHODS: Qualitative semi-structured interviews were performed with PCPs in Ontario, Canada. Interviews were structured using the theoretical domains framework (TDF) to explore determinants of breast cancer screening best-practice behaviours: (1) risk assessment; (2) discussion regarding benefits and harms; and (3) referral for screening. ANALYSIS: Interviews were transcribed and analyzed iteratively until saturation. Transcripts were coded deductively by behaviour and TDF domain. Data that did not fit within a TDF code were coded inductively. The research team met repeatedly to identify potential themes that influenced or were important consequences of the screening behaviours. The themes were tested against further data, disconfirming cases, and different PCP demographics. RESULTS: Eighteen physicians were interviewed. The theme of perceived guideline clarity (a lack of clarity on guideline-concordant practices) influenced all behaviours and moderated the extent to which the risk assessment and discussion occurred. Many were unaware of how risk-assessment factored into the guidelines and/or did not perceive that a shared-care discussion was guideline-concordant. Deferral to patient preference (screening referral without a complete discussion of benefits and harms) occurred when the PCPs had low knowledge regarding harms and/or if they experienced regret (TDF domain: emotion) resulting from prior clinical experiences. Older providers described patient’s influence impacting their decisions and physicians trained outside Canada, practicing in higher-resourced areas, and female physicians described being influenced by beliefs about consequences of benefits of screening. CONCLUSION: Perceived guideline clarity is an important driver of physician behaviour. Improving guideline concordant care should start by clarifying the guideline itself. Thereafter, targeted strategies include building skills in identifying and overcoming emotional factors and communication skills important for evidence-based screening discussions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-023-02190-w.
format Online
Article
Text
id pubmed-9942408
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99424082023-02-22 Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49 Nadler, Michelle B. Corrado, Ann Marie Wilson, Brooke E. Desnoyers, Alexandra Amir, Eitan Ivers, Noah Desveaux, Laura BMC Womens Health Research BACKGROUND: Canadian and US Task Forces recommend against routine mammography screening for women age 40–49 at average breast cancer risk as harms outweigh benefits. Both suggest individualized decisions based on the relative value women place on potential screening benefits and harms. Population-based data reveal variation in primary care professionals (PCPs) mammography rates in this age group after adjusting for sociodemographic factors, highlighting the need to explore PCP screening perspectives and how this informs clinical behaviours. Results from this study will inform interventions that can improve guideline concordant breast screening for this age group. METHODS: Qualitative semi-structured interviews were performed with PCPs in Ontario, Canada. Interviews were structured using the theoretical domains framework (TDF) to explore determinants of breast cancer screening best-practice behaviours: (1) risk assessment; (2) discussion regarding benefits and harms; and (3) referral for screening. ANALYSIS: Interviews were transcribed and analyzed iteratively until saturation. Transcripts were coded deductively by behaviour and TDF domain. Data that did not fit within a TDF code were coded inductively. The research team met repeatedly to identify potential themes that influenced or were important consequences of the screening behaviours. The themes were tested against further data, disconfirming cases, and different PCP demographics. RESULTS: Eighteen physicians were interviewed. The theme of perceived guideline clarity (a lack of clarity on guideline-concordant practices) influenced all behaviours and moderated the extent to which the risk assessment and discussion occurred. Many were unaware of how risk-assessment factored into the guidelines and/or did not perceive that a shared-care discussion was guideline-concordant. Deferral to patient preference (screening referral without a complete discussion of benefits and harms) occurred when the PCPs had low knowledge regarding harms and/or if they experienced regret (TDF domain: emotion) resulting from prior clinical experiences. Older providers described patient’s influence impacting their decisions and physicians trained outside Canada, practicing in higher-resourced areas, and female physicians described being influenced by beliefs about consequences of benefits of screening. CONCLUSION: Perceived guideline clarity is an important driver of physician behaviour. Improving guideline concordant care should start by clarifying the guideline itself. Thereafter, targeted strategies include building skills in identifying and overcoming emotional factors and communication skills important for evidence-based screening discussions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-023-02190-w. BioMed Central 2023-02-20 /pmc/articles/PMC9942408/ /pubmed/36803461 http://dx.doi.org/10.1186/s12905-023-02190-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nadler, Michelle B.
Corrado, Ann Marie
Wilson, Brooke E.
Desnoyers, Alexandra
Amir, Eitan
Ivers, Noah
Desveaux, Laura
Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title_full Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title_fullStr Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title_full_unstemmed Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title_short Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
title_sort perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40–49
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942408/
https://www.ncbi.nlm.nih.gov/pubmed/36803461
http://dx.doi.org/10.1186/s12905-023-02190-w
work_keys_str_mv AT nadlermichelleb perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT corradoannmarie perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT wilsonbrookee perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT desnoyersalexandra perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT amireitan perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT iversnoah perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049
AT desveauxlaura perceivedguidelineclarityimpactsguidelineconcordantcareforbreastcancerscreeninginwomenage4049